Although previous studies using targeted DNA methylation approaches have reported the general effects of IDH1 and IDH2 mutations on DNA methylation [6, 7, 10, 15], genome-wide methylation analysis in primary AML samples has not yet been described. The gene discussed is IDH2; the disease is acute myeloid leukemia.